
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading contract research organization in High Peak is seeking an Associate Data Scientist to analyze data and generate reports. This hybrid role involves working closely with clients and scientific teams. Ideal candidates will have a relevant degree, understanding of microarray technologies, and strong analytical skills. The position offers a comprehensive benefits package and opportunities for career growth while contributing to health and well-being improvements globally.
For 75years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well‑being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
Do you have expertise in, and a passion for data analysis?
Have you got the desire to improve health and lives?
Charles River Discovery are recruiting for an Associate Data Scientist to join our High Peak, UK site on an initial 12-month Fixed Term Contract. This is a hybrid role, with regular travel to the High Peak site required for the role.
The Associate Data Scientist will expertly analyse data generated by a bespoke microarray platform to generate high quality reports for our clients in adherence to set service level agreements and deadlines.
This would be a fantastic role for someone with a scientific background looking to utilise their skills in a data driven role with the opportunity to work closely with clients and Project Leaders.
Candidates must have full and permanent Right to Work in the UK before applying, as we are not able to offer sponsorship for this role.
Discovery from Charles River is industry‑proven in the successful development of novel therapies, with over 350 patents and 80 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.
Charles River is an early‑stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non‑GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 20,000 employees within 110 facilities in over 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well‑being of many across the globe. We have proudly supported the development of 86% of the drugs approved by the FDA in 2021.
At Charles River Laboratories, we recognize and recruit all talent. We are a company committed to the principle of diversity and inclusion and work daily in this direction.